These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28607325)
1. Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma. Lee C; Kim B; Song B; Moon KC J Pathol Transl Med; 2017 Jul; 51(4):359-364. PubMed ID: 28607325 [TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of nuclear expression of PHF2 and C/EBPα in clear cell renal cell carcinoma with consideration of adipogenic metabolic evolution. Park JH; Jung M; Moon KC Oncotarget; 2018 Jan; 9(1):142-151. PubMed ID: 29416602 [TBL] [Abstract][Full Text] [Related]
3. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma. Lee C; Park JW; Suh JH; Moon KC Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917 [TBL] [Abstract][Full Text] [Related]
4. PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer. Lee KH; Park JW; Sung HS; Choi YJ; Kim WH; Lee HS; Chung HJ; Shin HW; Cho CH; Kim TY; Li SH; Youn HD; Kim SJ; Chun YS Oncogene; 2015 May; 34(22):2897-909. PubMed ID: 25043306 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase. Yang J; Ma J; Xiong Y; Wang Y; Jin K; Xia W; Chen Q; Huang J; Zhang J; Jiang N; Jiang S; Ma D J Cell Physiol; 2018 Sep; 233(9):6841-6852. PubMed ID: 29336484 [TBL] [Abstract][Full Text] [Related]
6. PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival. Högner A; Krause H; Jandrig B; Kasim M; Fuller TF; Schostak M; Erbersdobler A; Patzak A; Kilic E Urol Oncol; 2018 Mar; 36(3):94.e1-94.e14. PubMed ID: 29169846 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens. Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170 [TBL] [Abstract][Full Text] [Related]
8. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595 [TBL] [Abstract][Full Text] [Related]
9. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma. Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival. Du P; Ye L; Yang Y; Jiang WG Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774 [TBL] [Abstract][Full Text] [Related]
12. Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma. Minardi D; Lucarini G; Milanese G; Di Primio R; Montironi R; Muzzonigro G Urol Oncol; 2016 Aug; 34(8):338.e11-8. PubMed ID: 27085487 [TBL] [Abstract][Full Text] [Related]
13. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759 [TBL] [Abstract][Full Text] [Related]
14. VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma. Lkhagvadorj S; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M J Lifestyle Med; 2014 Mar; 4(1):64-70. PubMed ID: 26064856 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression and its prognostic significance in clear cell renal cell carcinoma. Lee JW; Park JH; Suh JH; Nam KH; Choe JY; Jung HY; Chae JY; Moon KC Korean J Pathol; 2012 Jun; 46(3):237-45. PubMed ID: 23110009 [TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma. Park MJ; Baek HW; Rhee YY; Lee C; Park JW; Kim HW; Moon KC J Pathol Transl Med; 2015 Jan; 49(1):37-43. PubMed ID: 25812656 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression. Jung M; Lee C; Park JH; Moon KC Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995 [TBL] [Abstract][Full Text] [Related]
18. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival. Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660 [TBL] [Abstract][Full Text] [Related]
19. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma. Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274 [TBL] [Abstract][Full Text] [Related]
20. Expression of Neural Wiskott-Aldrich Syndrome Protein in Clear Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features. Liu GH; Chen J; Ji ZG; Zhou L Urol Int; 2015; 95(1):79-85. PubMed ID: 25115631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]